ruthenium has been researched along with Cancer of Colon in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Csuvik, O; Dömötör, O; Enyedy, ÉA; May, NV; Mészáros, JP; Pivarcsik, T; Spengler, G; Szatmári, I | 1 |
| Christou, YA; Dietis, N; Georgiades, SN; Ilmi, R; Odysseos, AD; Pitris, C; Stylianou, P; Tseriotou, E; Ttofi, I | 1 |
| Chakraborty, T; Guo, Z; Jin, G; Mandal, A; Roy, A; Roy, S; Zhao, Z | 1 |
| Arsenijević, A; Arsenijević, N; Ćoćić, D; Lazić, D; Milovanović, J; Milovanović, M; Rilak Simović, A; Scheurer, A; Stojanović, B | 1 |
| Dömötör, O; Enyedy, ÉA; Grgurić-Šipka, S; May, NV; Poljarević, JM; Savić, AR; Spengler, G; Tamás Gál, G | 1 |
| Chakraborty, T; Das, R; Ghosh, B; Roy, S | 1 |
| Berger, W; Heffeter, P; Keppler, BK; Klose, MHM; Koellensperger, G; Kornauth, C; Meier-Menches, SM; Theiner, S | 1 |
| Arumugam, P; Ju, H; Kulsi, G; Purushothaman, B; Samson, AAS; Song, JM | 1 |
| Bileck, A; Cichna-Markl, M; Gerner, C; Kreutz, D; Meier-Menches, SM; Tahir, A; Zappe, K | 1 |
| Bian, L; Chakraborty, T; Chanda, P; Ghosh, T; Roy, S; Wang, Y | 1 |
| Baliza, IRS; Batista, AA; Bezerra, DP; Correa, RS; Dias, RB; Rocha, CAG; Sales, CBS; Silva, SLR; Soares, MBP | 1 |
| Chard, RA; Jang, T; Walsby, CJ; Webb, MI; Wong, EW; Wong, MQ; Wu, B; Yapp, DT | 1 |
| Biersack, B; Mahal, K; Schobert, R; Spoerlein-Guettler, C | 1 |
| Ciudad, C; Florindo, P; Helena Garcia, M; Morais, TS; Moreno, V; Noe, V; Piedade, MF | 1 |
| Ali, M; Boff, B; Collin, JP; Fetzer, L; Gaiddon, C; Pfeffer, M; Sirlin, C; Xiangjun, M | 1 |
| Berdel, WE; Keppler, BK; Kreuser, ED; Piest, A; Thiel, E | 1 |
| Berger, MR; Galeano, A; Keppler, BK | 1 |
| Berger, MR; Garzon, FT; Keppler, BK; Schmähl, D | 1 |
| Gebbers, JO; Otto, HF | 1 |
19 other study(ies) available for ruthenium and Cancer of Colon
| Article | Year |
|---|---|
8-Hydroxyquinoline-Amino Acid Hybrids and Their Half-Sandwich Rh and Ru Complexes: Synthesis, Anticancer Activities, Solution Chemistry and Interaction with Biomolecules.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Cell Proliferation; Colonic Neoplasms; Coordination Complexes; Humans; Oxyquinoline; Rhodium; Ruthenium; Tumor Cells, Cultured | 2021 |
A Novel Conjugate of Bis[((4-bromophenyl)amino)quinazoline], a EGFR-TK Ligand, with a Fluorescent Ru(II)-Bipyridine Complex Exhibits Specific Subcellular Localization in Mitochondria.
Topics: Cell Proliferation; Colonic Neoplasms; ErbB Receptors; Extranodal Extension; Fluorescent Dyes; Glioblastoma; Humans; Mitochondria; Protein Kinase Inhibitors; Quinazolines; Ruthenium; Subcellular Fractions | 2019 |
Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events.
Topics: Aberrant Crypt Foci; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Biphenyl Compounds; Cell Proliferation; Cell Survival; Colon; Colonic Neoplasms; DNA; Female; Free Radical Scavengers; HT29 Cells; Humans; Kidney; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; NF-kappa B; Oxidation-Reduction; Phloretin; Picrates; Ruthenium; Spectroscopy, Fourier Transform Infrared; Sulfonic Acids; Toxicity Tests | 2020 |
A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug:
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Coordination Complexes; DNA; Guanosine Monophosphate; Histidine; Male; Methionine; Mice, Inbred BALB C; Molecular Docking Simulation; Pyrazoles; Pyridines; Ruthenium; Serum Albumin, Human; Tumor Burden | 2021 |
Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Coordination Complexes; Crystallography, X-Ray; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Molecular Conformation; Picolinic Acids; Ruthenium; Solubility; Toluene | 2018 |
Deciphering the biochemical and molecular mechanism underlying the in vitro and in vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents; Apoptosis; Colonic Neoplasms; Dextran Sulfate; Female; HT29 Cells; Humans; Intestinal Mucosa; Male; Molecular Structure; Quercetin; Rats, Sprague-Dawley; Rats, Wistar; Ruthenium; Toxicity Tests | 2018 |
Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Female; Laser Therapy; Mass Spectrometry; Mice; Mice, Inbred BALB C; Molecular Imaging; Organometallic Compounds; Osmium; Ruthenium; Tissue Distribution; Tumor Cells, Cultured | 2018 |
Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Coordination Complexes; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; HEK293 Cells; Humans; Mice, Nude; Mitochondria; Molecular Docking Simulation; Neoplastic Stem Cells; Reactive Oxygen Species; Ruthenium; Triazines | 2018 |
Time-dependent shotgun proteomics revealed distinct effects of an organoruthenium prodrug and its activation product on colon carcinoma cells.
Topics: Antineoplastic Agents; Colonic Neoplasms; HCT116 Cells; Humans; Organometallic Compounds; Prodrugs; Proteome; Proteomics; Ruthenium | 2019 |
Construing the Biochemical and Molecular Mechanism Underlying the
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Biphenyl Compounds; Catalase; Cell Proliferation; Colonic Neoplasms; Colorectal Neoplasms; Flavanones; Glutathione; HT29 Cells; Humans; Male; Picrates; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ruthenium; Superoxide Dismutase; TOR Serine-Threonine Kinases | 2019 |
Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling.
Topics: Apoptosis; Cell Line, Tumor; Colon; Colonic Neoplasms; DNA Damage; HCT116 Cells; Humans; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Ruthenium; Signal Transduction; Thymine; Tumor Suppressor Protein p53 | 2019 |
Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Humans; Hydrophobic and Hydrophilic Interactions; Indazoles; Ligands; Molecular Structure; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Serum Albumin | 2013 |
Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Coordination Complexes; Cymenes; DNA; Female; Ferrous Compounds; Humans; Metallocenes; Monoterpenes; Naphthoquinones; Ruthenium; Uterine Cervical Neoplasms | 2014 |
Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Crystallography, X-Ray; DNA; Humans; Ligands; Microscopy, Atomic Force; Organometallic Compounds; Pancreatic Neoplasms; Ruthenium | 2009 |
Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Organometallic Compounds; Ruthenium | 2011 |
Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines.
Topics: Carcinoma; Colonic Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Interferon-alpha; Interferon-beta; Interferon-gamma; Interferons; Ruthenium; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Antitumor activity of some ruthenium derivatives in human colon cancer cell lines in vitro.
Topics: Antineoplastic Agents; Colonic Neoplasms; Humans; Ruthenium; Tumor Cells, Cultured | 1992 |
Comparative antitumor activity of ruthenium derivatives with 5'-deoxy-5-fluorouridine in chemically induced colorectal tumors in SD rats.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Dimethylnitrosamine; Floxuridine; Imidazoles; Male; Organometallic Compounds; Rats; Rats, Inbred Strains; Rectal Neoplasms; Ruthenium | 1987 |
Electron microscope studies on the intestine using ruthenium red.
Topics: Animals; Biopsy; Colitis, Ulcerative; Colonic Neoplasms; Coloring Agents; Guinea Pigs; Humans; Intestinal Mucosa; Intestines; Lysosomes; Macrophages; Mice; Microscopy, Electron; Polyps; Rabbits; Rats; Rectal Neoplasms; Ruthenium; Staining and Labeling; Whipple Disease | 1974 |